Noa Shafran
Impact in
-
- Antibiotic Use and Resistance
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 1
-
- Respiratory viral infections research 2
- Co-authors
- Amir Shlomai (4 shared papers)Haim Ben‐Zvi (2 shared papers)Elad Goldberg (2 shared papers)Ella H. Sklan (2 shared papers)Inbal Shafran (2 shared papers)Ilan Krause (1 shared paper)Liron Sheena (1 shared paper)Hillel Halkin (1 shared paper)
- Journals
- Journal of Travel Medicine (1 paper)JHEP Reports (1 paper)Scientific Reports (1 paper)Critical Care (1 paper)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- IsraelAustriaUnited States
In The Last Decade
Noa Shafran
7 papers receiving 239 citations
Peers
Comparison fields: 5 of 73
- Applied Microbiology and Biotechnology 28
- Infectious Diseases 95
- Pharmacology 32
- Critical Care and Intensive Care Medicine 18
- Molecular Medicine 11
Countries citing papers authored by Noa Shafran
This map shows the geographic impact of Noa Shafran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Shafran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Shafran more than expected).
Fields of papers citing papers by Noa Shafran
This network shows the impact of papers produced by Noa Shafran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Shafran. The network helps show where Noa Shafran may publish in the future.
Co-authors
The 25 scholars most cited alongside Noa Shafran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 121 | |
| 2 | 1985 | 56 | |
| 3 | 2020 | 28 | |
| 4 | 2021 | 21 | |
| 5 | 2017 | 12 | |
| 6 | 2015 | 4 | |
| 7 | 2025 | 1 |
About Noa Shafran
Noa Shafran is a scholar working on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine, having authored 7 papers that have together received 243 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Advanced Breast Cancer Therapies (2 papers), Respiratory viral infections research (2 papers), Cardiac electrophysiology and arrhythmias (1 paper), Plant Pathogens and Fungal Diseases (1 paper), Breast Cancer Treatment Studies (1 paper), Cardiac Arrhythmias and Treatments (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (28 citations), Infectious Diseases (95 citations), Pharmacology (32 citations), Critical Care and Intensive Care Medicine (18 citations) and Molecular Medicine (11 citations). Noa Shafran has collaborated with scholars based in Israel, Austria and United States. Frequent co-authors include Amir Shlomai, Haim Ben‐Zvi, Elad Goldberg, Ella H. Sklan, Inbal Shafran, Ilan Krause, Liron Sheena, Hillel Halkin, U. Martinowitz and H Bank. Their work appears in journals such as Journal of Travel Medicine, JHEP Reports, Scientific Reports, Critical Care and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.